The effects of pricing policy on the prices and supply of low-cost medicines in Shandong, China: evidence from an interrupted time series analysis

[1] Wirtz VJ(2017)Essential medicines for universal health coverage Lancet 389 403-476

[2] Hogerzeil HV(2014)A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka BMC Public Health 14 817-e237

[3] Gray AL(2015)Toward a European definition for a drug shortage: a qualitative study Front Pharmacol 6 253-650

[4] Bigdeli M(2010)Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces BMC Health Serv Res 10 211-159

[5] de Joncheere CP(2013)Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China Lancet Glob Health 1 e227-229

[6] Ewen MA(2016)Current situation, determinants, and solutions to drug shortages in Shaanxi Province, China: a qualitative study PLoS One 11 e0165183-1050

[7] Gyansa-Lutterodt M(2013)A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study BMC Pharmacol Toxicol 14 1-e806

[8] Jing S(2016)The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians Expert Rev Pharmacoecon Outcomes Res 16 639-37

[9] Luiza VL(2014)Preventing shortages of biologic medicines Expert Rev Clin Pharmacol 7 151-355

[10] Mbindyo RM(2010)Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China Health Policy Plan 25 219-623

[1] Wirtz VJ(2017)Essential medicines for universal health coverage Lancet 389 403-476

[2] Hogerzeil HV(2014)A national survey on availability, price and affordability of selected essential medicines for non communicable diseases in Sri Lanka BMC Public Health 14 817-e237

[3] Gray AL(2015)Toward a European definition for a drug shortage: a qualitative study Front Pharmacol 6 253-650

[4] Bigdeli M(2010)Availability and use of essential medicines in China: manufacturing, supply, and prescribing in Shandong and Gansu provinces BMC Health Serv Res 10 211-159

[5] de Joncheere CP(2013)Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China Lancet Glob Health 1 e227-229

[6] Ewen MA(2016)Current situation, determinants, and solutions to drug shortages in Shaanxi Province, China: a qualitative study PLoS One 11 e0165183-1050

[7] Gyansa-Lutterodt M(2013)A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study BMC Pharmacol Toxicol 14 1-e806

[8] Jing S(2016)The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians Expert Rev Pharmacoecon Outcomes Res 16 639-37

[9] Luiza VL(2014)Preventing shortages of biologic medicines Expert Rev Clin Pharmacol 7 151-355

[10] Mbindyo RM(2010)Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China Health Policy Plan 25 219-623